{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:02:06Z","timestamp":1792087326622,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40120-025-00751-9","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T02:07:32Z","timestamp":1747274852000},"page":"1419-1438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["What Patients Don\u2019t Say and Physicians Don\u2019t Ask: A Needs Assessment in Myasthenia Gravis Integrating Patient and Healthcare Professional Perspectives"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4079-5560","authenticated-orcid":false,"given":"Cornelia","family":"Reyes Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Vlaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Foss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channa","family":"Hewamadduma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lehnerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Monin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Weisshardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"751_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JND-170294","volume":"5","author":"A Behin","year":"2018","unstructured":"Behin A, Le Panse R. New pathways and therapeutic targets in autoimmune myasthenia gravis. J Neuromuscul Dis. 2018;5:265\u201377.","journal-title":"J Neuromuscul Dis"},{"key":"751_CR2","volume":"2011","author":"NE Gilhus","year":"2011","unstructured":"Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA. Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis. 2011;2011:847393.","journal-title":"Autoimmune Dis"},{"key":"751_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren J. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30.","journal-title":"Nat Rev Dis Primers"},{"key":"751_CR4","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s40120-023-00544-y","volume":"12","author":"CA Hartford","year":"2023","unstructured":"Hartford CA, et al. Experience of daily life with generalized myasthenia gravis: a qualitative investigation and assessment of instrument content validity. Neurol Ther. 2023;12:2079\u201399.","journal-title":"Neurol Ther"},{"key":"751_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.596981","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ. Myasthenia gravis: autoantibody specificities and their role in MG management. Front Neurol. 2020;11:596981.","journal-title":"Front Neurol"},{"key":"751_CR6","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","volume":"269","author":"S Lehnerer","year":"2022","unstructured":"Lehnerer S, et al. Burden of disease in myasthenia gravis: taking the patient\u2019s perspective. J Neurol. 2022;269:3050\u201363.","journal-title":"J Neurol"},{"key":"751_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s40120-021-00285-w","volume":"10","author":"N Law","year":"2021","unstructured":"Law N, Davio K, Blunck M, Lobban D, Seddik K. The lived experience of myasthenia gravis: a patient-led analysis. Neurol Ther. 2021;10:1103\u201325.","journal-title":"Neurol Ther"},{"key":"751_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40120-022-00408-x","volume":"12","author":"K Jackson","year":"2023","unstructured":"Jackson K, Parthan A, Lauher-Charest M, Broderick L, Law N, Barnett C. Understanding the symptom burden and impact of myasthenia gravis from the patient\u2019s perspective: a qualitative study. Neurol Ther. 2023;12:107\u201328.","journal-title":"Neurol Ther"},{"key":"751_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s11606-014-2895-9","volume":"29","author":"LP Forsythe","year":"2014","unstructured":"Forsythe LP, et al. A systematic review of approaches for engaging patients for research on rare diseases. J Gen Intern Med. 2014;29:788\u2013800.","journal-title":"J Gen Intern Med"},{"key":"751_CR10","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s11606-020-05994-w","volume":"35","author":"KA Smith","year":"2020","unstructured":"Smith KA, et al. Improving empathy in healthcare consultations\u2014a secondary analysis of interventions. J Gen Intern Med. 2020;35:3007\u201314.","journal-title":"J Gen Intern Med"},{"key":"751_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/hex.14180","volume":"27","author":"C Cox","year":"2024","unstructured":"Cox C, Hatfield T, Willars J, Fritz Z. Identifying facilitators and inhibitors of shared understanding: an ethnography of diagnosis communication in acute medical settings. Health Expect. 2024;27:e14180.","journal-title":"Health Expect"},{"key":"751_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5146","volume":"341","author":"G Elwyn","year":"2010","unstructured":"Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ. 2010;341:c5146.","journal-title":"BMJ"},{"key":"751_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1370\/afm.1239","volume":"9","author":"RM Epstein","year":"2011","unstructured":"Epstein RM, Street RL Jr. The values and value of patient-centered care. Ann Fam Med. 2011;9:100\u20133.","journal-title":"Ann Fam Med"},{"key":"751_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1472-6963-13-231","volume":"13","author":"LP H\u00f6lzel","year":"2013","unstructured":"H\u00f6lzel LP, Kriston L, H\u00e4rter M. Patient preference for involvement, experienced involvement, decisional conflict, and satisfaction with physician: a structural equation model test. BMC Health Serv Res. 2013;13:231.","journal-title":"BMC Health Serv Res"},{"key":"751_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/hex.12052","volume":"18","author":"E Tambuyzer","year":"2015","unstructured":"Tambuyzer E, Van Audenhove C. Is perceived patient involvement in mental health care associated with satisfaction and empowerment? Health Expect. 2015;18:516\u201326.","journal-title":"Health Expect"},{"key":"751_CR16","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1007\/s00415-021-10902-1","volume":"269","author":"LK Andersen","year":"2022","unstructured":"Andersen LK, Jakobsson AS, Revsbech KL, Vissing J. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis. J Neurol. 2022;269:3086\u201393.","journal-title":"J Neurol"},{"key":"751_CR17","unstructured":"Barry S, Monin N, De Backer M, Reyes Acosta C, Vlaev I, Weisshardt I. Is virtual reality an effective educational tool to enhance patient\u2013physician dialogue? ENGAGE learning intervention [presentation]. EAN 2023. Presentation EPR-059."},{"key":"751_CR18","unstructured":"Weisshardt I, Reyes Acosta C, Vlaev I, Monin N, Barry S. Going beyond knowledge; skills when assessing the impact of an immersive learning program in myasthenia gravis (MG) utilising virtual reality (VR)\u2014the ENGAGE research design [poster]. Fifteenth Annual European CME Forum 2022."},{"key":"751_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1748-5908-9-11","volume":"9","author":"JM Huijg","year":"2014","unstructured":"Huijg JM, Gebhardt WA, Crone MR, Dusseldorp E, Presseau J. Discriminant content validity of a theoretical domains framework questionnaire for use in implementation research. Implement Sci. 2014;9:11.","journal-title":"Implement Sci"},{"key":"751_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fneur.2020.00604","volume":"11","author":"ME Farrugia","year":"2020","unstructured":"Farrugia ME, Goodfellow JA. A practical approach to managing patients with myasthenia gravis\u2014opinions and a review of the literature. Front Neurol. 2020;11:604.","journal-title":"Front Neurol"},{"key":"751_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/17439760.2016.1262613","volume":"12","author":"V Clarke","year":"2017","unstructured":"Clarke V, Braun V. Thematic analysis. J Posit Psychol. 2017;12:297\u20138.","journal-title":"J Posit Psychol"},{"key":"751_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/160940690600500107","volume":"5","author":"J Fereday","year":"2006","unstructured":"Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5:80\u201392.","journal-title":"Int J Qual Methods"},{"key":"751_CR23","first-page":"163","volume-title":"Doing qualitative research","author":"BF Crabtree","year":"1999","unstructured":"Crabtree BF, Miller WL. A template approach to text analysis: developing and using codebooks. In: Crabtree BF, Miller WL, editors. Doing qualitative research. California: Sage; 1999. p. 163\u201377."},{"key":"751_CR24","first-page":"67","volume-title":"Transforming qualitative information: thematic analysis and code development","author":"RE Boyatzis","year":"1998","unstructured":"Boyatzis RE. Developing themes and a code using the inductive method. In: Boyatzis RE, editor. Transforming qualitative information: thematic analysis and code development. California: Sage; 1998. p. 67\u201399."},{"key":"751_CR25","volume-title":"Qualitative research methods: a health focus","author":"P Liamputtong","year":"1999","unstructured":"Liamputtong P, Ezzy D. Qualitative research methods: a health focus. Melbourne: Oxford University Press; 1999."},{"key":"751_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11017-010-9161-x","volume":"32","author":"H Carel","year":"2011","unstructured":"Carel H. Phenomenology and its application in medicine. Theor Med Bioeth. 2011;32:33\u201346.","journal-title":"Theor Med Bioeth"},{"key":"751_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/S40037-019-0509-2","volume":"8","author":"BE Neubauer","year":"2019","unstructured":"Neubauer BE, Witkop CT, Varpio L. How phenomenology can help us learn from the experiences of others. Perspect Med Educ. 2019;8:90\u20137.","journal-title":"Perspect Med Educ"},{"key":"751_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13909","volume":"27","author":"I Nielssen","year":"2024","unstructured":"Nielssen I, et al. Operationalizing the principles of patient engagement through a patient advisory council: lessons and recommendations. Health Expect. 2024;27:e13909.","journal-title":"Health Expect"},{"key":"751_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40900-023-00522-6","volume":"9","author":"F Ferra","year":"2023","unstructured":"Ferra F, et al. Implementation and evaluation of participatory advisory boards in mental health research: a research protocol of the \u201cPART-Beirat\u201d project. Res Involv Engagem. 2023;9:112.","journal-title":"Res Involv Engagem"},{"key":"751_CR30","first-page":"1","volume":"2","author":"M Stein","year":"2024","unstructured":"Stein M, et al. The telemedical platform MyaLink for remote monitoring in myasthenia gravis\u2014rationale and protocol for a proof of concept study. J Neuromuscul Dis. 2024;2:1\u20138.","journal-title":"J Neuromuscul Dis."}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00751-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:52:14Z","timestamp":1757170334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00751-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00751-9","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct the affiliation for author Alexis Rodriguez.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Cornelia Reyes Acosta has nothing to disclose. At the time of the study, she was a Consultant for LLH Concepts GbR. Since manuscript development, she further holds a position in the Digital Health & Applied Tech Assessment research division at the Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK. Ivo Vlaev has received consulting fees, research or institutional support and educational grants from AtomicPR, Barclays Bank, Boehringer Ingelheim, Ernst & Young, Kindred Agency, MC&T, McDonald\u2019s, Ogilvy, Pfizer, Prime Global Medical Communications, Swiss Re Ltd. and UCB. He has received speaker fees from Teva UK Limited. Alexis Rodriguez has nothing to disclose. Allison Foss is part of the argenx Leadership Council. Ashwin Pinto has received funding for consultancy on scientific or educational advisory boards for argenx, Terumo BCT and UCB. Channa Hewamadduma has received funding for consultancy on scientific or educational advisory boards for argenx, Biogen, Lupin, Roche and UCB, and has received an investigator-led research grant from UCB. His study activities were supported by a Sheffield NIHR BRC UK centre grant. He is a Trustee of the myasthenia gravis patient organization Myaware. John Vissing has been a Consultant on advisory boards for Amicus Therapeutics, Biogen, Edgewise Therapeutics, Fulcrum Therapeutics, Genethon, Horizon Therapeutics (now Amgen), Lupin, ML Biopharma, Novartis, Regeneron Pharmaceuticals, Roche, Sanofi Genzyme (now Sanofi), Sarepta Therapeutics and UCB. He has received research and travel support and\/or speaker honoraria from Alexion Pharmaceuticals, argenx, Biogen, Edgewise Therapeutics, Fulcrum Therapeutics, Lupin, Sanofi Genzyme (now Sanofi) and UCB. He is a Principal Investigator in clinical trials for Alexion Pharmaceuticals, argenx, Atamyo Therapeutics, Genethon, Horizon Therapeutics (now Amgen), Janssen Pharmaceuticals (now Johnson & Johnson Innovative Medicine), ML Biopharma, Novartis, Regeneron Pharmaceuticals, Roche, Sanofi Genzyme (now Sanofi) and UCB. Nicholas J. Silvestri is a Consultant\/Adviser for Alexion Pharmaceuticals, Amgen, Annexon Biosciences, argenx, Immunovant, Janssen Pharmaceuticals (now Johnson & Johnson Innovative Medicine) and UCB; he is a Speaker for Alexion Pharmaceuticals, argenx, Takeda Pharmaceuticals and UCB. Sophie Lehnerer has received speaker or consultancy honoraria or financial research support (paid to her institution) from Alexion, argenx, Biogen, Hormosan, HUMA, Johnson & Johnson, Merck, Roche and UCB. Marc De Backer, Natasha Monin and Sophie Barry are employees and shareholders of UCB. Ina Weisshardt has received consulting fees from Heel, ILAE, ISHH, Janssen and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Institutional Review Board approval for the overall ENGAGE program, including this needs assessment, was granted by the University of Warwick, UK (Ethical Application Reference: HSSREC 41\/22-23). The needs assessment was carried out in accordance with the principles of the Declaration of Helsinki. Surveys were designed in accordance with both the Data Protection Act 2018 and the General Data Protection Regulation. Informed consent was captured from the participants prior to their participation in the interview, and survey data were captured anonymously, password protected and stored on a secure server. Interviews were conducted following consent from participants. Primary data were only available to essential members of the research team at LLH Concepts, unless explicit consent was received from the respective participant. Participants consented to the publication of their insights.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}